Aspirin lowers VTE recurrence: study

Lead author Professor John Simes, director of the NHMRC Clinical Trials Centre at the University of Sydney, said two clinical trials investigated the effect of aspirin on the prevention of recurrent venous thromboembolism in people who had already suffered a pulmonary embolism or deep vein thrombosis – the warfarin and acetylsalicylic acid study (WARFASA) and the Aspirin to Prevent Recurr